Sarah Kelliher, MB (she/her/hers)

Clinical Research Fellow
UCD Conway SPHERE Research Group, Conway Institute, University College Dublin, Dublin, Ireland, Dublin, Ireland

Sarah Kelliher (MB) is an early-career clinician-scientist undertaking doctoral studies at the Conway SPHERE Research Group at University College Dublin. Dr Kelliher is supported by the Wellcome-Health Research Board Irish Clinical and Academic Training (ICAT) programme. Alongside her clinical training as a haematology specialist registrar, she is undertaking research characterising mechanisms of hypercoagulability in Myeloproliferative Neoplasms (The EMPRESS Study) under the primary supervision of Dr Barry Kevane. Dr Kelliher was recently awarded an ISTH Training Fellowship to be hosted by Dr Anandi Krishnan at Stanford University. Using a multi-omics approach from large independent clinical cohorts, Dr Krishnan and Dr Kelliher are investigating the platelet proteo-transcriptomic signature from patients with Myeloproliferative Neoplasms.

Presentation(s):

• OC 16.5 - Rivaroxaban in Combination with Low-Dose Aspirin Is Associated With A Reduction in Pro-Inflammatory and Pro-Thrombotic Circulating Vesicle Signatures in Patients With Cardiovascular Disease

  Sunday, June 25, 2023
  11:45 – 12:00 ET

• OC 25.6 - The Impact of Coagulation on Peripartum Outcomes

  Sunday, June 25, 2023
  14:45 – 16:00 ET

• OC 56.1 - Platelets as Versatile Effectors of Thromboinflammation: an MPN multi-omics collaborative

  Tuesday, June 27, 2023
  10:45 – 11:00 ET